| 1. |
Amylin, a calcitonin hormone secreted by pancreatic β-cells, prevents bone loss, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1425,
2004,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 2. |
Vascular targeting agents for the treatment of cancer |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1425,
2004,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 3. |
Outcomes research should come after marketing approval of the product, says US FDA Commissioner |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1425,
2004,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 4. |
Antibacterial intervention"highly successful"in Switzerland |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1425,
2004,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 5. |
Light-activated verteporfin*can induce good response and favourable cosmesis in patients with multiple nonmelanoma skin cancers, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1425,
2004,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 6. |
The nucleoside reverse transcriptase inhibitor DPC 817*markedly reduced HIV viral load |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1425,
2004,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 7. |
Pravastatin + aspirin decreases risk of CVD |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1425,
2004,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 8. |
Tiotropium bromide the new GOLD standard for COPD management? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1425,
2004,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 9. |
Rituximab plus CHOP induction beneficial in aggressive NHL |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1425,
2004,
Page 11-11
RH Carlson,,
Preview
|
|
摘要:
The addition of the anti-CD20 monoclonal antibody rituximab [Rituxan] to the standard chemotherapy regimen of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) significantly prolongs the time to treatment failure in elderly patients with diffuse large B-cell non-Hodgkin's lymphoma (NHL), according to a study presented at the 45th Annual Meeting of the American Society of Hematology [San Diego, US; December 2003]. Induction therapy with rituximab plus CHOP (R-CHOP) did not significantly improve the overall response rate, compared with CHOP alone; however, it did increase the median time to treatment failure. Maintenance therapy with rituximab also improved the time to treatment failure, compared with observation, in patients who had responded to induction therapy with CHOP alone, but not those who had received the R-CHOP regimen.
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 10. |
Preoperative COX-2 inhibitors: opioid-sparing analgesia |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1425,
2004,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
首页
